2013-6-25 By : APEIR CO

dsc0058(mod).jpg
(88.8 KB)
dsc0061(mod).jpg
(67.6 KB)

dsc0075-1(mod).jpg
(103.7 KB)
dsc0085(mod).jpg
(25.1 KB)

dsc0098(mod).jpg
(102.2 KB)
dsc0102(mod).jpg
(89.7 KB)

dsc0108(mod).jpg
(79.8 KB)
dsc0125(mod).jpg
(69 KB)

dsc0126(mod).jpg
(79.2 KB)
dsc0130(mod).jpg
(80 KB)

dsc0132(mod).jpg
(79.7 KB)
dsc0139(mod).jpg
(86.4 KB)

dsc0140(mod).jpg
(96.4 KB)
dsc0146(mod).jpg
(84 KB)

dsc0164(mod).jpg
(65.5 KB)
dsc0169(mod).jpg
(96.5 KB)

dsc0173(mod).jpg
(75.8 KB)
dsc0181(mod).jpg
(50.5 KB)

dsc0182(mod).jpg
(92.8 KB)
dsc0191(mods).jpg
(90.5 KB)

dsc0218(mod).jpg
(101.4 KB)



H7N9: Lesson Learned from China Experience
Of recent studies, we now know that H7N9 is highly pathogenic in human, low pathogenic in animal and still evolves; thus, this makes it hard to produce effective vaccine against the virus. The NA genes of virus can be found in wild birds whose migratory routes along the eastern Asian flyway. This information suggests the possible outbreak in related countries. So it is important to enhance H7N9 surveillance among poultry and wild birds, and improve pathogen identification of severe pneumonia patients. For clinical management, signs of infection are similar to many influenza which makes it hard for viral detection in the early stage of infection. Oseltamivir is proved to be effective treatment for early infected patients and duration of treatment is advised to last till throat swab test negative twice in succession. (2013-6-25) (2013-6-25)